Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.710
-0.013 (-1.83%)
Dec 3, 2024, 12:10 PM EST - Market open
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $181.68 million as of December 3, 2024. Its market cap has increased by 59.93% in one year.
Market Cap
181.68M
Enterprise Value
73.46M
1-Year Change
59.93%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $181.68M, a decrease of -68.44%. That is a compound annual growth rate of -12.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 185.00M | 2.72% |
| Dec 29, 2023 | 180.10M | -24.71% |
| Dec 30, 2022 | 239.20M | -59.17% |
| Dec 31, 2021 | 585.90M | -29.78% |
| Dec 31, 2020 | 834.40M | 561.17% |
| Dec 31, 2019 | 126.20M | -79.02% |
| Dec 31, 2018 | 601.40M | -3.93% |
| Dec 29, 2017 | 626.00M | 118.35% |
| Dec 30, 2016 | 286.70M | -50.19% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InfuSystem Holdings | 192.01M |
| scPharmaceuticals | 185.65M |
| Heron Therapeutics | 185.56M |
| Inhibikase Therapeutics | 185.45M |
| Senseonics Holdings | 185.33M |
| Procaps Group | 183.34M |
| Zura Bio | 182.82M |
| KORU Medical Systems | 182.43M |